A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
Open accessAbstract
Fumaric acid esters (FAEs) such as dimethylfumarate (DMF) are used for the treatment of adults with moderate‐to‐severe psoriasis. The mode of action of FAEs is complex. Here, we provide a comprehensive review of the literature to describe the molecular mechanisms by which DMF and its active metabolite monomethylfumarate (MMF) exert their anti‐inflammatory and immune modulatory effects. MMF can bind to the hydroxy‐carboxylic acid receptor 2 (HCA2) on the cell surface and both DMF and MMF react with intracellular glutathione following cell penetration. DMF and to some extent also MMF modulate the activity of certain cellular signalling proteins such as the nuclear factor (erythroid‐derived 2)‐like 2 (Nrf2), nuclear factor kappa B (Nf‐κB) and the cellular concentration of cyclic adenosine monophosphate. Some studies show that DMF can also affect the hypoxia‐inducible factor 1‐alpha (HIF‐1α). These actions seem to be responsible for i) the downregulation of inflammatory cytokines and ii) an overall shift from a proinflammatory Th1/Th17 response to an anti‐inflammatory/regulatory Th2 response. Both steps are necessary for the amelioration of psoriatic inflammation, although additional mechanisms have been proposed. There is a growing body of evidence to support the notion that DMF/MMF may also exert effects on granulocytes and non‐immune cell lineages including keratinocytes and endothelial cells. A better understanding of the multiple molecular mechanisms involved in the cellular action of FAEs will help to adapt and further improve the use of such small molecules for the treatment of psoriasis and other chronic inflammatory diseases.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Fumarate causes HIF stabilisation even under normoxic conditions (pseudohypoxia), a hallmark of FH-deficient tumours.
“Accordingly, fumarate causes HIF stabilisation, even under normoxic conditions, i.e. pseudohypoxia, a hallmark of FH-deficient tumours93.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [93]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Neutrophil recruitment and function in health and inflammation
Kolaczkowska, E., & Kubes, P. (2013) · Nature Reviews Immunology · doi:10.1038/nri3399 · Cited by 5,472 · see citing works
Differentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452 · see citing works
Nestle, F. O., Kaplan, D. H., & Barker, J. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804595 · Cited by 2,788 · see citing works
Development, cytokine profile and function of human interleukin 17-producing helper T cells
Wilson, N. J., Boniface, K., Chan, J. R., McKenzie, B. S., Blumenschein, W. M., Mattson, J. D., Basham, B., Smith, K., Chen, T., Morel, F., et al. (2007) · Nature Immunology · doi:10.1038/ni1497 · Cited by 2,035 · see citing works
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis
Gold, R., Kappos, L., Arnold, D. L., Bar‐Or, A., Giovannoni, G., Selmaj, K. W., Tornatore, C., Sweetser, M. T., Yang, M., Sheikh, S. I., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114287 · Cited by 1,735 · see citing works
Lowes, M. A., Suárez‐Fariñas, M., & Krueger, J. G. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120225 · Cited by 1,710 · see citing works
Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways
Nair, R. P., Duffin, K. C., Helms, C. A., Ding, J., Stuart, P. E., Goldgar, D. E., Gudjonsson, J. E., Li, Y., Tejasvi, T., Feng, B., et al. (2009) · Nature Genetics · doi:10.1038/ng.311 · Cited by 1,414 · see citing works
Activation of interleukin-6 gene expression through the NF-kappa B transcription factor.
Libermann, T. A., & Baltimore, D. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.5.2327 · Cited by 1,372 · see citing works
Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
Fox, R. J., Miller, D. H., Phillips, J. T., Hutchinson, M., Havrdová, E., Kita, M., Yang, M., Raghupathi, K., Novas, M., Sweetser, M. T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206328 · Cited by 1,353 · see citing works
Linker, R. A., Lee, D.-H., Ryan, S., van Dam, A. M., Conrad, R., Bista, P., Zeng, W., Hronowsky, X., Buko, A., Chollate, S., et al. (2011) · Brain · doi:10.1093/brain/awq386 · Cited by 1,155 · see citing works
Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity
Collaborative Association Study of Psoriasis (CASP), Tsoi, L. C., Genetic Analysis of Psoriasis Consortium, Psoriasis Association Genetics Extension, Wellcome Trust Case Control Consortium 2, Spain, S. L., Knight, J., Ellinghaus, E., Stuart, P. E., Capon, F., et al. (2012) · Nature Genetics · doi:10.1038/ng.2467 · Cited by 1,024 · see citing works
Interleukin-36–Receptor Antagonist Deficiency and Generalized Pustular Psoriasis
Marrakchi, S., Guigue, P., Renshaw, B. R., Puel, A., Pei, X.-Y., Fraitag, S., Zribi, J., Bal, É., Cluzeau, C. V. M., Chrabieh, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1013068 · Cited by 996 · see citing works
Lee, E., Trepicchio, W. L., Oestreicher, J. L., Pittman, D. D., Wang, F., Chamian, F. N., Dhodapkar, M. V., & Krueger, J. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20030451 · Cited by 900 · see citing works
Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
Ganguly, D., Chamilos, G., Lande, R., Gregorio, J. D., Meller, S., Facchinetti, V., Homey, B., Barrat, F. J., Żal, T., & Gilliet, M. F. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090480 · Cited by 742 · see citing works
Sequence and Haplotype Analysis Supports HLA-C as the Psoriasis Susceptibility 1 Gene
Nair, R. P., Stuart, P. E., Nistor, I., Hiremagalore, R., Chia, N. V. C., Jenisch, S., Weichenthal, M., Abecasis, G. R., Lim, H. W., Christophers, E., et al. (2006) · The American Journal of Human Genetics · doi:10.1086/503821 · Cited by 602 · see citing works
Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease.
Racke, M. K., Bonomo, A. C., Scott, D. E., et al. (1994) · The Journal of Experimental Medicine · doi:10.1084/jem.180.5.1961 · Cited by 601 · see citing works
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
Lande, R., Botti, E., Jandus, C., Dojcinovic, D., Fanelli, G., Conrad, C., Chamilos, G., Feldmeyer, L., Marinari, B., Chon, S. Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms6621 · Cited by 541 · see citing works
Chronically Inflamed Human Tissues Are Infiltrated by Highly Differentiated Th17 Lymphocytes
Pène, J., Chevalier, S., Preisser, L., Vénéreau, E., Guilleux, M.-H., Ghannam, S., Molès, J., Danger, Y., Ravon, E., Saux, S. L., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7423 · Cited by 529 · see citing works
Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns
Peterson, J. D., Herzenberg, L. A., Vasquez, K. O., & Waltenbaugh, C. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3071 · Cited by 508 · see citing works
Guidelines of care for the management of psoriasis and psoriatic arthritis
Menter, A., Korman, N. J., Elmets, C. A., Feldman, S. R., Gelfand, J. M., Gordon, K. B., Gottlieb, A. B., Koo, J. Y. M., Lebwohl, M., Lim, H. W., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.12.032 · Cited by 478 · see citing works
Scannevin, R. H., Chollate, S., Jung, M.-Y., Shackett, M. N., Patel, H., Bista, P., Zeng, W., Ryan, S. T., Yamamoto, M. P., Lukashev, M., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.190132 · Cited by 461 · see citing works
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease
Ghoreschi, K., Thomas, P. T., Breit, S., Dugas, M., Mailhammer, R., van Eden, W., van der Zee, R., Biedermann, T., Prinz, J. C., Mack, M., et al. (2002) · Nature Medicine · doi:10.1038/nm804 · Cited by 453 · see citing works
Self-citationNast, A., Gisondi, P., Ormerod, A., et al. (2015) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13354 · Cited by 420 · see citing works
IL-23 Promotes Maintenance but Not Commitment to the Th17 Lineage
Stritesky, G. L., Yeh, N., & Kaplan, M. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.5948 · Cited by 417 · see citing works
Angiogenesis drives psoriasis pathogenesis
Heidenreich, R., Röcken, M., & Ghoreschi, K. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2009.00669.x · Cited by 386 · see citing works
Self-citationCommon variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis
Hüffmeier, U., Uebe, S., Ekici, A. B., Bowes, J., Giardina, E., Korendowych, E., Juneblad, K., Apel, M., McManus, R., Ho, P., et al. (2010) · Nature Genetics · doi:10.1038/ng.688 · Cited by 372 · see citing works
Melanocyte antigen triggers autoimmunity in human psoriasis
Arakawa, A., Siewert, K., Stöhr, J., Besgen, P., Kim, S.-M., Rühl, G., Nickel, J., Vollmer, S., Thomas, P. T., Krebs, S., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20151093 · Cited by 361 · see citing works
Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells
Ghoreschi, K., Brück, J., Kellerer, C., Deng, C., Peng, H., Rothfuss, O. C., Hussain, R. Z., Gocke, A. R., Respa, A., Glocova, I., et al. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20100977 · Cited by 352 · see citing works
Self-citationWilms, H., Sievers, J., Rickert, U., Rostami‐Yazdi, M., Mrowietz, U., & Lucius, R. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-30 · Cited by 346 · see citing works
IL-6 Signaling in Psoriasis Prevents Immune Suppression by Regulatory T Cells
Goodman, W. A., Levine, A. D., Massari, J. V., Sugiyama, H., McCormick, T. S., & Cooper, K. D. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803721 · Cited by 329 · see citing works
Current and future management of psoriasis
Menter, A., & Griffiths, C. E. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61129-5 · Cited by 319 · see citing works
Chemoprevention through the Keap1–Nrf2 signaling pathway by phase 2 enzyme inducers
Kwak, M.-K., Wakabayashi, N., & Kensler, T. W. (2004) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2004.06.041 · Cited by 311 · see citing works
Fumarate Is Cardioprotective via Activation of the Nrf2 Antioxidant Pathway
Ashrafian, H., Czibik, G., Bellahcene, M., Aksentijević, D., Smith, A. C., Mitchell, S. J., Dodd, M. S., Kirwan, J., Byrne, J. J., Ludwig, C., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.017 · Cited by 303 · see citing works
Antipsoriatic effect of fumaric acid derivatives
Altmeyer, P. J., Mattlies, U., Pawlak, F., Hoffmann, K., Frosch, P. J., Ruppert, P., Wassilew, S. W., Horn, T. D., Kreysel, H. W., Lutz, G., et al. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70121-0 · Cited by 300 · see citing works
Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate’s protective effect in EAE
Chen, H., Assmann, J. C., Krenz, A., Rahman, M., Grimm, M., Karsten, C. M., Köhl, J., Offermanns, S., Wettschureck, N., & Schwaninger, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72151 · Cited by 298 · see citing works
A classification of psoriasis vulgaris according to phenotype
Griffiths, C. E. M., Christophers, E., Barker, J. N., et al. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07675.x · Cited by 295 · see citing works
S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update
Nast, A., Boehncke, W., Mrowietz, U., Ockenfels, H. M., Philipp, S., Reich, K., Rosenbach, T., Sammain, A., Schlaeger, M., Sebastian, M., et al. (2012) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2012.07919.x · Cited by 272 · see citing works
Hinz, M., Lemke, P., Anagnostopoulos, I., Hacker, C., Krappmann, D., Mathas, S., Dörken, B., Zenke, M., Stein, H., & Scheidereit, C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020062 · Cited by 267 · see citing works
Biswas, C., Shah, N., Muthu, M., La, P., Fernando, A. P., Sengupta, S., Yang, G., & Dennery, P. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.567685 · Cited by 259 · see citing works
Chui, R. W., & Dorovini‐Zis, K. (2010) · Journal of Neuroinflammation · doi:10.1186/1742-2094-7-1 · Cited by 250 · see citing works
Dimethylfumarate Is a Potent Inducer of Apoptosis in Human T Cells
Treumer, F., Zhu, K., Gläser, R., et al. (2003) · Journal of Investigative Dermatology · doi:10.1111/j.1523-1747.2003.12605.x · Cited by 249 · see citing works
Psoriasis—recent advances in understanding its pathogenesis and treatment
Krueger, G. G., & Ellis, C. N. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.04.035 · Cited by 243 · see citing works
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
Walters, R. W., Shukla, A. K., Kovacs, J. J., Violin, J. D., DeWire, S. M., Lam, C. M., Chen, J. R., Muehlbauer, M. J., Whalen, E. J., & Lefkowitz, R. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36806 · Cited by 240 · see citing works
Formaldehyde in brain: an overlooked player in neurodegeneration?
Tulpule, K., & Dringen, R. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12356 · Cited by 238 · see citing works
Self-citationA strategy for cancer prevention: Stimulation of the Nrf2-ARE signaling pathway
Zhang, Y., & Gordon, G. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.885.3.7 · Cited by 231 · see citing works
Trepicchio, W. L., Ozawa, M., Walters, I. B., Kikuchi, T., Gilleaudeau, P., Bliss, J. L., Schwertschlag, U. S., Dorner, A. J., & Krueger, J. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6910 · Cited by 217 · see citing works
Mrowietz, Christophers, & Aci, A. F. T. G. F. (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03034.x · Cited by 215 · see citing works
Effects of dimethyl fumarate on neuroprotection and immunomodulation
Albrecht, P., Bouchachia, I., Goebels, N., Henke, N., Hofstetter, H., Issberner, A., Kovacs, Z., Lewerenz, J., Lisak, D., Maher, P., et al. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-163 · Cited by 213 · see citing works
Dimethylfumarate for psoriasis: more than a dietary curiosity
Mrowietz, U., & Asadullah, K. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.11.003 · Cited by 206 · see citing works
Dimethylfumarate Inhibits TNF-Induced Nuclear Entry of NF-κB/p65 in Human Endothelial Cells
Loewe, R. P., Holnthoner, W., Gröger, M., Pillinger, M., Грубер, Ф., Mechtcheriakova, D., Hofer, E., Wolff, K. S., & Petzelbauer, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4781 · Cited by 198 · see citing works
Hanson, J., Gille, A., Zwykiel, S., Lukasova, M., Clausen, B. E., Ahmed, K., Tunaru, S., Wirth, A., & Offermanns, S. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42273 · Cited by 197 · see citing works
Peng, H., Guerau‐de‐Arellano, M., Mehta, V. B., Yang, Y., Huss, D. J., Papenfuss, T. L., Lovett‐Racke, A. E., & Racke, M. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.383380 · Cited by 196 · see citing works
Guenova, E., Skabytska, Y., Hoetzenecker, W., Weindl, G., Sauer, K., Tham, M., Kim, K., Park, J., Seo, J. H., Ignatova, D., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416922112 · Cited by 191 · see citing works
Self-citationReduction of CD8 + T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
Spencer, C. M., Crabtree‐Hartman, E., Lehmann‐Horn, K., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000076 · Cited by 189 · see citing works
Brennan, M. S., Matos, M. F., Li, B., Hronowski, X., Gao, B., Juhasz, P., Rhodes, K. J., & Scannevin, R. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120254 · Cited by 188 · cited 1× · see citing works
“[55] TABLE 2 Chemical structure and basic properties of FA, DMF, MMF and MEF (adapted from Brennan et al. 2015)[40] Compound Molecular formula Molecular weight Melting points (°C) Molecular structure Fumaric acid C4H4O4 116.07 287 DMF C6H8O4 144.13 102 MMF C5H6O4 130.1 144 MEF C6H8O4 144.13 147 F…”
BackgroundInfluentialThe role of transcription factor Nrf2 in skin cells metabolism
Gęgotek, A., & Skrzydlewska, E. (2015) · Archives of Dermatological Research · doi:10.1007/s00403-015-1554-2 · Cited by 180 · see citing works
Mechanism of Chemical Activation of Nrf2
Li, Y., Paonessa, J. D., & Zhang, Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035122 · Cited by 179 · see citing works
Wu, Q., Wang, Q., Mao, G., Dowling, C. A., Lundy, S. K., & Mao‐Draayer, Y. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601532 · Cited by 179 · see citing works
Gold, R., Linker, R. A., & Stangel, M. (2011) · Clinical Immunology · doi:10.1016/j.clim.2011.02.017 · Cited by 173 · see citing works
DMF, but not other fumarates, inhibits NF-κB activity in vitro in an Nrf2-independent manner
Gillard, G. O., Collette, B., Anderson, J., Chao, J., Scannevin, R. H., Huss, D. J., & Fontenot, J. D. (2015) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2015.04.006 · Cited by 173 · see citing works
Ockenfels, Schultewolter, Ockenfels, Funk, & Goos (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02400.x · Cited by 161 · see citing works
Lehmann, J. C. U., Listopad, J. J., Rentzsch, C., Igney, F. H., von Bonin, A., Hennekes, H., Asadullah, K., & Döcke, W. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700686 · Cited by 160 · see citing works
Vandermeeren, M., Janssens, S., Borgers, M. J., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6570 · Cited by 159 · see citing works
Xie, X., Zhao, Y. C., Ma, C., Xu, X., Zhang, Y., Wang, C., Jin, J., Shen, X., Gao, J., Li, N., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13184 · Cited by 155 · see citing works
Interleukin 10 Treatment of Psoriasis
Asadullah, K., Döcke, W. D., Ebeling, M., Friedrich, M., Belbe, G., Audring, H., Volk, H., & Sterry, W. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.2.187 · Cited by 151 · see citing works
Mrowietz, U., Szepietowski, J. C., Loewe, R. P., van de Kerkhof, P., Lamarca, R., Ocker, W. G., Tebbs, V. M., & Pau‐Charles, I. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14947 · Cited by 151 · see citing works
Self-citationHerpes zoster as a risk factor for stroke and TIA
Breuer, J., Pacou, M., Gauthier, A., & Brown, M. M. (2014) · Neurology · doi:10.1212/wnl.0000000000000038 · Cited by 142 · see citing works
Pharmacokinetics of oral fumarates in healthy subjects
Litjens, N. H. R., Burggraaf, J., van Strijen, E., et al. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02145.x · Cited by 142 · see citing works
Dimethyl fumarate treatment alters circulating T helper cell subsets in multiple sclerosis
Groß, C. C., Schulte‐Mecklenbeck, A., Klinsing, S., Posevitz‐Fejfár, A., Wiendl, H., & Klotz, L. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000183 · Cited by 142 · see citing works
Fumaric Acid and its Esters: An Emerging Treatment for Multiple Sclerosis
Moharregh-Khiabani, D., Linker, R., Gold, R., & Stangel, M. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602788 · Cited by 139 · see citing works
Schmidt, T. J., Ak, M., & Mrowietz, U. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.053 · Cited by 139 · see citing works
Kastrati, I., Siklos, M. I., Calderon-Gierszal, E. L., El-Shennawy, L., Georgieva, G., Thayer, E., Thatcher, G., & Frasor, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679704 · Cited by 129 · see citing works
Detoxication enzyme inducers modify cytokine production in rat mixed glial cells.
Wierinckx, A., Brevé, J., Mercier, D., Schultzberg, M., Drukarch, B., & van Dam, A. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.05.013 · Cited by 128 · see citing works
Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters
Werdenberg, D., Joshi, R., Wolffram, S., et al. (2003) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.364 · Cited by 126 · see citing works
Recent advances in understanding psoriasis
Eberle, F. C., Brück, J., Holstein, J., Hirahara, K., & Ghoreschi, K. (2016) · F1000Research · doi:10.12688/f1000research.7927.1 · Cited by 126 · see citing works
Self-citationThe psoriasis drug monomethylfumarate is a potent nicotinic acid receptor agonist
Tang, H. L., Lu, J. Y.-L., Zheng, X., et al. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.041 · Cited by 125 · see citing works
Reich, K., Blaschke, V., Maurer, C., Lippert, U., Neumann, C. R., Garbe, C., Middel, P., & Westphal, G. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01248.x · Cited by 124 · see citing works
McInnes, I. B., Illei, G. G., Danning, C. L., Yarboro, C. H., Crane, M., Kuroiwa, T., Schlimgen, R., Lee, E., Foster, B. A., Flemming, D. J., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.7.4075 · Cited by 123 · see citing works
Stoof, T. J., Flier, J., Sampat-Sardjoepersad, S. C., Nieboer, C., Tensen, C. P., & Boorsma, D. M. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04220.x · Cited by 119 · see citing works
Dimethyl fumarate selectively reduces memory T cells in multiple sclerosis patients
Longbrake, E. E., Ramsbottom, M. J., Cantoni, C., et al. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515608961 · Cited by 115 · see citing works
Inhibition of Dendritic Cell Differentiation by Fumaric Acid Esters
Zhu, K., & Mrowietz, U. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01159.x · Cited by 114 · see citing works
Bimodal immune activation in psoriasis
Christophers, E., Metzler, G., & Röcken, M. (2013) · British Journal of Dermatology · doi:10.1111/bjd.12631 · Cited by 114 · see citing works
Systemic therapy with fumaric acid derivates: New possibilities in the treatment of psoriasis
Nieboer, C., de Hoop, D., Loenen, A. C. V., et al. (1989) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(89)70071-2 · Cited by 111 · see citing works
McGuire, V. A., Diez, T. R.-Z., Emmerich, C. H., Strickson, S., Ritorto, M. S., Sutavani, R. V., Weiβ, A., Houslay, K. F., Knebel, A., Meakin, P. J., et al. (2016) · Scientific Reports · doi:10.1038/srep31159 · Cited by 110 · see citing works
Characterization of Mononuclear Cell Infiltrates in Psoriatic Lesions
Bjerke, J. R., Krogh, H. K., & Matre, R. (1978) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12529841 · Cited by 108 · see citing works
Fumaric Acid Esters Suppress Peripheral CD4- and CD8-Positive Lymphocytes in Psoriasis
Höxtermann, S., Nüchel, C., & Altmeyer, P. J. (1998) · Dermatology · doi:10.1159/000017903 · Cited by 106 · see citing works
Litjens, N. H. R., Rademaker, M., Ravensbergen, B., et al. (2004) · European Journal of Immunology · doi:10.1002/eji.200324174 · Cited by 105 · see citing works
The Pharmacokinetics of Fumaric Acid Esters Reveal Their In Vivo Effects
Mrowietz, U., Morrison, P. J., Suhrkamp, I., Kumanova, M., & Clement, B. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.11.002 · Cited by 102 · see citing works
Fumaric acid therapy for psoriasis: A randomized, double-blind, placebo-controlled study
Nugteren‐Huying, W. M., van der Schroeff, J. G., Hermans, J. J. R., et al. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(08)80766-9 · Cited by 100 · see citing works
Nicolay, J., Müller-Decker, K., Schroeder, A. E., Brechmann, M., Möbs, M., Géraud, C., Assaf, C., Goerdt, S., Krammer, P., & Gülow, K. (2016) · Blood · doi:10.1182/blood-2016-01-694117 · Cited by 98 · see citing works
Debets, R., Hegmans, J. P., Croughs, P., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.6.2955 · Cited by 94 · see citing works
Yazdi, M. R., & Mrowietz, U. (2008) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2008.07.001 · Cited by 93 · see citing works
Nieboer, C., de Hoop, D., Langendijk, P. N. J., Loenen, A. C. V., & Gubbels, J. W. (2009) · Dermatologica · doi:10.1159/000247856 · Cited by 92 · see citing works
Wong, H. L., Costa, G. L., Lotze, M. T., & Wahl, S. M. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.177.3.775 · Cited by 88 · see citing works
Dimethyl fumarate – only an anti‐psoriatic medication?
Meißner, M., Valesky, E. M., Kippenberger, S., & Kaufmann, R. (2012) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2012.07996.x · Cited by 84 · see citing works
Borgers, M. J., Beyaert, R., Borghmans, I., et al. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.00211.x · Cited by 83 · see citing works
García‐Caballero, M., Marí‐Beffa, M., Medina, M. Á., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2010.416 · Cited by 80 · see citing works
IL-4 suppresses IL-1 beta, TNF-alpha and PGE2 production by human peritoneal macrophages.
Hart, P. H., Cooper, R., & Finlay‐Jones, J. J. (1991) · PubMed · Cited by 80 · see citing works
Friedrich, M., Döcke, W., Klein, A., et al. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.01731.x · Cited by 79 · see citing works
GPR109A and Vascular Inflammation
Chai, J. T., Digby, J. E., & Choudhury, R. P. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0325-9 · Cited by 77 · see citing works
Immunopathogenesis of Psoriasis
Ozawa, M., & Aiba, S. (2004) · Current Drug Targets - Inflammation & Allergy · doi:10.2174/1568010043343868 · Cited by 77 · see citing works
Rostami‐Yazdi, M., Clement, B., Schmidt, T., Schinor, D., & Mrowietz, U. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.197 · Cited by 76 · see citing works
Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients
Rostami‐Yazdi, M., Clement, B., & Mrowietz, U. (2010) · Archives of Dermatological Research · doi:10.1007/s00403-010-1061-4 · Cited by 76 · see citing works
Dimethyl fumarate–induced lymphopenia in MS due to differential T-cell subset apoptosis
Ghadiri, M., Rezk, A., Li, R. Q., et al. (2017) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000340 · Cited by 76 · see citing works
Gerdes, S., Shakery, K., & Mrowietz, U. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07779.x · Cited by 75 · see citing works
Geisel, J., Brück, J., Glocova, I., Dengler, K., Sinnberg, T. W., Rothfuss, O. C., Walter, M. J., Schulze‐Osthoff, K., Röcken, M., & Ghoreschi, K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300556 · Cited by 75 · see citing works
Self-citationDimethylfumarate Impairs Neutrophil Functions
Müller, S., Behnen, M., Bieber, K., Möller, S., Hellberg, L., Witte, M., Hänsel, M., Zillikens, D., Solbach, W., Laskay, T., et al. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.361 · Cited by 75 · see citing works
de Martin, R., Mrowietz, U., Wiegrebe, W., Jirovský, D., Loewe, R. P., Pillinger, M., Gröger, M., Holnthoner, W., Wolff, K., & Petzelbauer, P. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01576.x · Cited by 74 · see citing works
Regulation of Neuronal Cell Adhesion Molecule Expression by NF-κB
Simpson, C. S., & MORRIS, B. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.22.16879 · Cited by 73 · see citing works
In vitro pharmacokinetics of anti-psoriatic fumaric acid esters
Litjens, N. H. R., van Strijen, E., van Gulpen, C., et al. (2004) · BMC Pharmacology · doi:10.1186/1471-2210-4-22 · Cited by 71 · see citing works
Kimball, A. B., Kawamura, T., Tejura, K., Boss, C., Hancox, A., Vogel, J. C., Steinberg, S. M., Turner, M. L. C., & Blauvelt, A. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.10.1341 · Cited by 71 · see citing works
Rubant, S., Ludwig, R. J., Diehl, S., Hardt, K., Kaufmann, R., Pfeilschifter, J. M., & Boehncke, W. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700996 · Cited by 70 · see citing works
Dibbert, S., Clement, B., Skak-Nielsen, T., Mrowietz, U., & Rostami‐Yazdi, M. (2013) · Archives of Dermatological Research · doi:10.1007/s00403-013-1332-y · Cited by 69 · see citing works
Gesser, B., Johansen, C., Rasmussen, M. K., et al. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700859 · Cited by 68 · see citing works
Effects of Monomethylfumarate on Human Granulocytes
Nibbering, P. H., Thio, B., Zomerdijk, T. P. L., et al. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12358715 · Cited by 67 · see citing works
Fumaric acid diesters deprive cultured primary astrocytes rapidly of glutathione
Schmidt, M., & Dringen, R. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.01.006 · Cited by 66 · see citing works
Self-citationMeißner, M., Doll, M., Hrgović, I., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.46 · Cited by 62 · see citing works
Roberti, M. L., Ricottini, L., Capponi, A., et al. (2014) · PubMed · Cited by 58 · see citing works
Thio, H. B., Zomerdijk, T. P. L., Oudshoorn, C., et al. (1994) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1994.tb08589.x · Cited by 57 · see citing works
Brennan, M. S., Patel, H., Allaire, N., Thai, A., Cullen, P. F., Ryan, S. T., Lukashev, M., Bista, P., Huang, R., Rhodes, K. J., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6622 · Cited by 57 · see citing works
Onderdijk, A. J., Baerveldt, E. M., Kurek, D., Kant, M., Florencia, E. F., Debets, R., & Prens, E. P. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401740 · Cited by 56 · see citing works
Wallbrecht, K., Drick, N., Hund, A., & Schön, M. P. (2011) · Experimental Dermatology · doi:10.1111/j.1600-0625.2011.01376.x · Cited by 53 · see citing works
Takegawa, S., Jin, Z. H., Nakayama, T., Oyama, T., Hieshima, K., Nagakubo, D., Shirakawa, A., Tsuzuki, T., Nakamura, S., & Yoshie, O. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2007.00687.x · Cited by 51 · see citing works
Angiogenesis: The New Potential Target for the Therapy of Psoriasis?
Heidenreich, R., Röcken, M., & Ghoreschi, K. (2008) · Drug News & Perspectives · doi:10.1358/dnp.2008.21.2.1188196 · Cited by 50 · see citing works
Self-citationHahn, M., & Ghoreschi, K. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2017.1279054 · Cited by 50 · see citing works
Self-citationDand, N., Mucha, S., Tsoi, L. C., Mahil, S. K., Stuart, P. E., Arnold, A., Baurecht, H., Burden, A. D., Duffin, K. C., Chandran, V., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx328 · Cited by 50 · see citing works
Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin
Hanson, J., Gille, A., & Offermanns, S. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.06.003 · Cited by 49 · see citing works
Kang, H.-J., Seo, H.-A., Go, Y., Oh, C. J., Jeoung, N. H., Park, K.-G., & Lee, I.-K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061411 · Cited by 49 · see citing works
IL‐4‐mediated fine tuning of IL‐12p70 production by human DC
Guenova, E., Volz, T., Sauer, K., Kaesler, S., Müller, M., Wölbing, F., Chen, K.-M., Schwärzler, C., Brossart, P., Röcken, M., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200838463 · Cited by 48 · see citing works
Rácz, E., Kurek, D., Kant, M., Baerveldt, E. M., Florencia, E. F., Mourits, S., de Ridder, D., Laman, J. D., van der Fits, L., & Prens, E. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019806 · Cited by 48 · see citing works
Moed, H. D., Stoof, T. J., BOORSMA, D. M., et al. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.02124.x · Cited by 45 · see citing works
Lifting the Silver Flakes: The Pathogenesis and Management of Chronic Plaque Psoriasis
Chong, H. T., Kopecki, Z., & Cowin, A. J. (2013) · BioMed Research International · doi:10.1155/2013/168321 · Cited by 43 · see citing works
Ghashghaeinia, M., Bobbala, D., Wieder, T., Koka, S., Brück, J., Fehrenbacher, B., Röcken, M., Schaller, M., Lang, F. J. W., & Ghoreschi, K. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00014.2010 · Cited by 41 · see citing works
Self-citationFumaric acid esters for psoriasis: a systematic review
Smith, D. J. (2016) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-016-1470-2 · Cited by 41 · see citing works
Numata, I., Okuyama, R., Memezawa, A., et al. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.119 · Cited by 40 · see citing works
Gesser, B., Rasmussen, M. K., Raaby, L., Rosada, C., Johansen, C., Kjellerup, R. B., Kragballe, K., & Iversen, L. (2011) · Inflammation Research · doi:10.1007/s00011-011-0316-7 · Cited by 40 · see citing works
Ryu, J., Kwon, M.-J., & Nam, T.-J. (2015) · Marine Drugs · doi:10.3390/md13084721 · Cited by 39 · see citing works
Tahvili, S., Zandieh, B., & Amirghofran, Z. (2015) · International Journal of Dermatology · doi:10.1111/ijd.12834 · Cited by 39 · see citing works
Dimethylfumarate for Psoriasis
Bovenschen, H. J., Langewouters, A. M. G., & van de Kerkhof, P. C. M. (2010) · American Journal of Clinical Dermatology · doi:10.2165/11533240-000000000-00000 · Cited by 38 · see citing works
Guidance on the diagnosis and clinical management of psoriasis
Cohen, S. N., Baron, S. E., & Archer, C. B. (2012) · Clinical and Experimental Dermatology · doi:10.1111/j.1365-2230.2012.04337.x · Cited by 37 · see citing works
Nutritional control of IL-23/Th17-mediated autoimmune disease through HO-1/STAT3 activation
Brück, J., Holstein, J., Glocova, I., et al. (2017) · Scientific Reports · doi:10.1038/srep44482 · Cited by 35 · see citing works
Self-citationDimethyl fumarate inhibits integrin α4 expression in multiple sclerosis models
Kihara, Y., Groves, A., Rivera, R. R., & Chun, J. J. M. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.251 · Cited by 34 · see citing works
Nationwide population‐based study of cause‐specific death rates in patients with psoriasis
Salahadeen, E., Torp-Pedersen, C. T., Gislason, G., Hansen, P. R., & Ahlehoff, O. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12523 · Cited by 34 · see citing works
Effects of monomethylfumarate on dendritic cell differentiation
Litjens, N. H. R., Rademaker, M., Ravensbergen, B., et al. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.07002.x · Cited by 34 · see citing works
Torales‐Cardeña, A., Martínez-Torres, I., Rodríguez–Martínez, S., Gómez‐Chávez, F., Cancino‐Díaz, J. C., Vázquez-Sánchez, E. A., & Cancino-Diaz, M. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/607363 · Cited by 33 · see citing works
Regulated genes in psoriatic skin during treatment with fumaric acid esters
Onderdijk, A. J., Balak, D., Baerveldt, E. M., Florencia, E. F., Kant, M., Laman, J. D., van IJcken, W. F. J., Rácz, E., de Ridder, D., Thio, H. B., et al. (2014) · British Journal of Dermatology · doi:10.1111/bjd.13128 · Cited by 33 · see citing works
Thiessen, A., Schmidt, M., & Dringen, R. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.03.048 · Cited by 31 · see citing works
Self-citationSchmidt, A. N., Robbins, J. B., Greer, J. P., et al. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.09.013 · Cited by 30 · see citing works
Neue Erkenntnisse zu Fumarsäureestern (Fumaderm®): Ergebnisse des 2. Experten‐Workshops
Mrowietz, U., Altmeyer, P. J., Augustin, M., et al. (2012) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0379.2012.08047.x · Cited by 29 · see citing works
Zoghi, S., Amirghofran, Z., Nikseresht, A., Ashjazadeh, N., Kamali‐Sarvestani, E., & Rezaei, N. (2011) · Immunological Investigations · doi:10.3109/08820139.2011.569626 · Cited by 27 · see citing works
Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1α (HIF-1α)
Zhao, G., Liu, Y., Fang, J., Chen, Y., Li, H., & Gao, K. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.062 · Cited by 27 · see citing works
Helwa, I., Patel, R. R., Karempelis, P., Kaddour‐Djebbar, I., Choudhary, V., & Bollag, W. B. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218818 · Cited by 27 · see citing works
Hoffmann, J. H. O., Schaekel, K., Hartl, D., Enk, A., & Hadaschik, E. N. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15839 · Cited by 27 · see citing works
Fumarate Esters as Angiogenesis Inhibitors: Key to Action in Psoriasis?
Arbiser, J. L. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.45 · Cited by 26 · see citing works
Dimethyl fumarate: a Janus-faced substance?
Kees, F. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.804912 · Cited by 26 · see citing works
Helwa, I., Choudhary, V., Chen, X., Kaddour‐Djebbar, I., & Bollag, W. B. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.239715 · Cited by 25 · see citing works
Sebök, B., Bonnekoh, B., Vetter, R., et al. (1999) · PubMed · Cited by 24 · see citing works
Balak, D. M. W., Hajdarbegovic, E., Bramer, W. M., et al. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14236 · Cited by 22 · see citing works
Drug evaluation: BG-12, an immunomodulatory dimethylfumarate.
Wakkee, M., & Thio, H. B. (2007) · PubMed · Cited by 20 · see citing works
Dimethyl fumarate protection against collagen II degradation
Li, Y., Tang, J., & Hu, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.10.005 · Cited by 19 · see citing works
Fiedler, S. E., Kerns, A. R., Tsang, C., Tsang, V., BOURDETTE, D. N., & Salinthone, S. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.021 · Cited by 17 · see citing works
Bonnekoh, B., Böckelmann, R., Ambach, A., et al. (2001) · Skin Pharmacology and Physiology · doi:10.1159/000056350 · Cited by 16 · see citing works
Regulation of Interleukin-23 Expression in Health and Disease
Welsby, I., & Goriely, S. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-94-024-0921-5_8 · Cited by 16 · see citing works
Haarmann, A., Nehen, M., Deiß, A., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160819086 · Cited by 15 · see citing works
Immune sensing of nucleic acids in inflammatory skin diseases
Demaria, O., Domizio, J. D., & Gilliet, M. F. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-014-0445-5 · Cited by 15 · see citing works
Eminel, S., Jin, N., Rostami, M., Dibbert, S., Mrowietz, U., & Suhrkamp, I. (2016) · Experimental Dermatology · doi:10.1111/exd.13138 · Cited by 15 · see citing works
Molès, J., Griez, A., Guilhou, J., Girard, C., Nagot, N., de Perre, P. V., & Dujols, P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169879 · Cited by 14 · see citing works
Dimethylfumarat “nur” ein Anti‐Psoriatikum?
Meißner, M., Valesky, E. M., Kippenberger, S., et al. (2012) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/j.1610-0387.2012.07996_suppl.x · Cited by 13 · see citing works
Lymphopenia and CD4+/CD8+ Cell Reduction under Fumaric Acid Esters
Sondermann, W., Rompoti, N., Leister, L., et al. (2017) · Dermatology · doi:10.1159/000478903 · Cited by 13 · see citing works
A defective purine nucleotide synthesis pathway in psoriatic patients.
Kiehl, R., & Ionescu, G. (1992) · Acta Dermato Venereologica · doi:10.2340/0001555572253255 · Cited by 10 · see citing works
Müller, S., Smatlik, N., Burian, M., et al. (2017) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2017.06.005 · Cited by 7 · see citing works
Schulze‐Topphoff, U., Varrin‐Doyer, M., Pekarek, K. L., et al. (2014) · Neurology · doi:10.1212/wnl.82.10_supplement.s53.006 · Cited by 6 · see citing works
Flagged first, then by citations
Research works printed but not linked: 169
- C. E. Griffiths, E. Christophers, J. N. Barker, R. J. Chalmers, S. Chimenti, G. G. Krueger, C. Leonardi, A. Menter, J. P. Ortonne, L. Fry, Br. J. Dermatol. 2007, 156, 258.
- F. O. Nestle, D. H. Kaplan, J. Barker, N. Engl. J. Med. 2009, 361, 496.
- A. Menter, C. E. Griffiths, Lancet 2007, 370, 272.
- H. T. Chong, Z. Kopecki, A. J. Cowin, Biomed. Res. Int. 2013, 2013, 168321.
- E. Salahadeen, C. Torp-Pedersen, G. Gislason, P. R. Hansen, O. Ahlehoff, J. Eur. Acad. Dermatol. Venereol. 2015, 29, 1002.
- G. Krueger, C. N. Ellis, J. Am. Acad. Dermatol. 2005, 53, S94.
- F. C. Eberle, J. Brück, J. Holstein, K. Hirahara, K. Ghoreschi, F1000Res. 2016, 5, 770.
- M. Ozawa, S. Aiba, Curr. Drug Targets Inflamm. Allergy 2004, 3, 137.
- E. Lee, W. L. Trepicchio, J. L. Oestreicher, D. Pittman, F. Wang, F. Chamian, M. Dhodapkar, J. G. Krueger, J. Exp. Med. 2004, 199, 125.
- M. A. Lowes, M. Suarez-Farinas, J. G. Krueger, Annu. Rev. Immunol. 2014, 32, 227.
- R. Heidenreich, M. Röcken, K. Ghoreschi, Int. J. Exp. Pathol. 2009, 90, 232.
- N. J. Wilson, K. Boniface, J. R. Chan, B. S. McKenzie, W. M. Blumenschein, J. D. Mattson, B. Basham, K. Smith, T. Chen, F. Morel, J. C. Lecron, R. A. Kastelein, D. J. Cua, T. K. McClanahan, E. P. Bowman, R. de Waal Malefyt, Nat. Immunol. 2007, 8, 950.
- I. Welsby, S. Goriely, Adv. Exp. Med. Biol. 2016, 941, 167.
- G. L. Stritesky, N. Yeh, M. H. Kaplan, J. Immunol. 2008, 181, 5948.
- R. Lande, E. Botti, C. Jandus, D. Dojcinovic, G. Fanelli, C. Conrad, G. Chamilos, L. Feldmeyer, B. Marinari, S. Chon, L. Vence, V. Riccieri, P. Guillaume, A. A. Navarini, P. Romero, A. Costanzo, E. Piccolella, M. Gilliet, L. Frasca, Nat. Commun. 2014, 5, 5621.
- J. P. Molès, A. Griez, J. J. Guilhou, C. Girard, N. Nagot, P. Van de Perre, P. Dujols, PLoS ONE 2017, 12, e0169879.
- D. Ganguly, G. Chamilos, R. Lande, J. Gregorio, S. Meller, V. Facchinetti, B. Homey, F. J. Barrat, T. Zal, M. Gilliet, J. Exp. Med. 2009, 206, 1983.
- O. Demaria, J. Di Domizio, M. Gilliet, Semin. Immunopathol. 2014, 36, 519.
- A. Arakawa, K. Siewert, J. Stöhr, P. Besgen, S. M. Kim, G. Rühl, J. Nickel, S. Vollmer, P. Thomas, S. Krebs, S. Pinkert, M. Spannagl, K. Held, C. Kammerbauer, R. Besch, K. Dornmair, J. C. Prinz, J. Exp. Med. 2015, 212, 2203.
- R. P. Nair, P. E. Stuart, I. Nistor, R. Hiremagalore, N. V. Chia, S. Jenisch, M. Weichenthal, G. R. Abecasis, H. W. Lim, E. Christophers, J. J. Voorhees, J. T. Elder, Am. J. Hum. Genet. 2006, 78, 827.
- N. Dand, S. Mucha, L. C. Tsoi, S. K. Mahil, P. E. Stuart, A. Arnold, H. Baurecht, A. D. Burden, K. Callis Duffin, V. Chandran, C. J. Curtis, S. Das, D. Ellinghaus, E. Ellinghaus, C. Enerback, T. Esko, D. D. Gladman, C. E. M. Griffiths, J. E. Gudjonsson, P. Hoffman, G. Homuth, U. Hüffmeier, G. G. Krueger, M. Laudes, S. H. Lee, W. Lieb, H. W. Lim, S. Löhr, U. Mrowietz, M. Müller-Nurayid, M. Nöthen, A. Peters, P. Rahman, A. Reis, N. J. Reynolds, E. Rodriguez, C. O. Schmidt, S. L. Spain, K. Strauch, T. Tejasvi, J. J. Voorhees, R. B. Warren, M. Weichenthal, S. Weidinger, M. Zawistowski, R. P. Nair, F. Capon, C. H. Smith, R. C. Trembath, G. R. Abecasis, J. T. Elder, A. Franke, M. A. Simpson, J. N. Barker, Hum. Mol. Genet. 2017, 26, 4301.
- R. P. Nair, K. C. Duffin, C. Helms, J. Ding, P. E. Stuart, D. Goldgar, J. E. Gudjonsson, Y. Li, T. Tejasvi, B. J. Feng, A. Ruether, S. Schreiber, M. Weichenthal, D. Gladman, P. Rahman, S. J. Schrodi, S. Prahalad, S. L. Guthery, J. Fischer, W. Liao, P. Y. Kwok, A. Menter, G. M. Lathrop, C. A. Wise, A. B. Begovich, J. J. Voorhees, J. T. Elder, G. G. Krueger, A. M. Bowcock, G. R. Abecasis; Collaborative Association Study of Psoriasis, Nat. Genet. 2009, 41, 199.
- L. C. Tsoi, S. L. Spain, J. Knight, E. Ellinghaus, P. E. Stuart, F. Capon, J. Ding, Y. Li, T. Tejasvi, J. E. Gudjonsson, H. M. Kang, M. H. Allen, R. McManus, G. Novelli, L. Samuelsson, J. Schalkwijk, M. Ståhle, A. D. Burden, C. H. Smith, M. J. Cork, X. Estivill, A. M. Bowcock, G. G. Krueger, W. Weger, J. Worthington, R. Tazi-Ahnini, F. O. Nestle, A. Hayday, P. Hoffmann, J. Winkelmann, C. Wijmenga, C. Langford, S. Edkins, R. Andrews, H. Blackburn, A. Strange, G. Band, R. D. Pearson, D. Vukcevic, C. C. Spencer, P. Deloukas, U. Mrowietz, S. Schreiber, S. Weidinger, S. Koks, K. Kingo, T. Esko, A. Metspalu, H. W. Lim, J. J. Voorhees, M. Weichenthal, H. E. Wichmann, V. Chandran, C. F. Rosen, P. Rahman, D. D. Gladman, C. E. Griffiths, A. Reis, J. Kere, Collaborative Association Study of Psoriasis (CASP); Genetic Analysis of Psoriasis Consortium; Psoriasis Association Genetics Extension; Wellcome Trust Case Control Consortium 2, R. P. Nair, A. Franke, J. N. Barker, G. R. Abecasis, J. T. Elder, R. C. Trembath, Nat. Genet. 2012, 44, 1341.
- U. Huffmeier, S. Uebe, A. B. Ekici, J. Bowes, E. Giardina, E. Korendowych, K. Juneblad, M. Apel, R. McManus, P. Ho, I. N. Bruce, A. W. Ryan, F. Behrens, J. Lascorz, B. Böhm, H. Traupe, J. Lohmann, C. Gieger, H. E. Wichmann, C. Herold, M. Steffens, L. Klareskog, T. F. Wienker, O. Fitzgerald, G. M. Alenius, N. J. McHugh, G. Novelli, H. Burkhardt, A. Barton, A. Reis, Nat. Genet. 2010, 42, 996.
- S. Marrakchi, P. Guigue, B. R. Renshaw, A. Puel, X. Y. Pei, S. Fraitag, J. Zribi, E. Bal, C. Cluzeau, M. Chrabieh, J. E. Towne, J. Douangpanya, C. Pons, S. Mansour, V. Serre, H. Makni, N. Mahfoudh, F. Fakhfakh, C. Bodemer, J. Feingold, S. Hadj-Rabia, M. Favre, E. Genin, M. Sahbatou, A. Munnich, J. L. Casanova, J. E. Sims, H. Turki, H. Bachelez, A. Smahi, N. Engl. J. Med. 2011, 365, 620.
- A. Nast, P. Gisondi, A. D. Ormerod, P. Saiag, C. Smith, P. I. Spuls, P. Arenberger, H. Bachelez, J. Barker, E. Dauden, E. M. de Jong, E. Feist, A. Jacobs, R. Jobling, L. Kemény, M. Maccarone, U. Mrowietz, K. A. Papp, C. Paul, K. Reich, S. Rosumeck, T. Talme, H. B. Thio, P. van de Kerkhof, R. N. Werner, N. Yawalkar, J. Eur. Acad. Dermatol. Venereol. 2015, 29, 2277.
- A. Menter, N. J. Korman, C. A. Elmets, S. R. Feldman, J. M. Gelfand, K. B. Gordon, A. Gottlieb, J. Y. Koo, M. Lebwohl, H. W. Lim, A. S. Van Voorhees, K. R. Beutner, R. Bhushan; American Academy of Dermatology, J. Am. Acad. Dermatol. 2009, 60, 643.
- D. Smith, Ir. J. Med. Sci. 2017, 186, 161.
- W. Schweckendiek, Med. Monatsschr. 1959, 13, 103.
- R. Kiehl, G. Ionescu, Acta Derm. Venereol. 1992, 72, 253.
- P. J. Altmeyer, U. Matthes, F. Pawlak, K. Hoffmann, P. J. Frosch, P. Ruppert, S. W. Wassilew, T. Horn, H. W. Kreysel, G. Lutz, J. Barth, I. Rietzschel, R. K. Joshi, J. Am. Acad. Dermatol. 1994, 30, 977.
- W. M. Nugteren-Huying, J. G. van der Schroeff, J. Hermans, D. Suurmond, J. Am. Acad. Dermatol. 1990, 22, 311.
- K. Ghoreschi, J. Brück, C. Kellerer, C. Deng, H. Peng, O. Rothfuss, R. Z. Hussain, A. R. Gocke, A. Respa, I. Glocova, N. Valtcheva, E. Alexander, S. Feil, R. Feil, K. Schulze-Osthoff, R. A. Rupec, A. E. Lovett-Racke, R. Dringen, M. K. Racke, M. Röcken, J. Exp. Med. 2011, 208, 2291.
- U. Mrowietz, J. C. Szepietowski, R. Loewe, P. van de Kerkhof, R. Lamarca, W. G. Ocker, V. M. Tebbs, I. Pau-Charles, Br. J. Dermatol. 2017, 176, 615.
- M. S. Brennan, M. F. Matos, B. Li, X. Hronowski, B. Gao, P. Juhasz, K. J. Rhodes, R. H. Scannevin, PLoS ONE. 2015, 10, e0120254.
- B. Sebök, B. Bonnekoh, J. Geisel, G. Mahrle, Eur. J. Pharmacol. 1994, 270, 79.
- B. Sebök, H. Gollnick, G. Mahrle, B. Bonnekoh, H&G Zeitschrift fur Hautkrankheiten. 2000, 76, 347.
- J. C. Lehmann, J. J. Listopad, C. U. Rentzsch, F. H. Igney, A. von Bonin, H. H. Hennekes, K. Asadullah, W. D. Docke, J. Invest. Dermatol. 2007, 127, 835.
- H. B. Thio, T. P. Zomerdijk, C. Oudshoorn, J. Kempenaar, P. H. Nibbering, J. G. van der Schroeff, M. Ponec, Br. J. Dermatol. 1994, 131, 856.
- G. O. Gillard, B. Collette, J. Anderson, J. Chao, R. H. Scannevin, D. J. Huss, J. D. Fontenot, J. Neuroimmunol. 2015, 283, 74.
- C. Nieboer, D. de Hoop, A. C. van Loenen, P. N. Langendijk, E. van Dijk, J. Am. Acad. Dermatol. 1989, 20, 601.
- M. Rostami Yazdi, U. Mrowietz, Clin. Dermatol. 2008, 26, 522.
- M. Brennan, N. Allaire, D. Huss, P. Cullen, A. Thai, S. Szak, A. Thomas, D. Gianni, J. Carulli, J. Fontenot, B. Wipke, K. Rhodes, R. Scannevin, Neurology 2014, 82, P1.206.
- M. Rostami-Yazdi, B. Clement, U. Mrowietz, Arch. Dermatol. Res. 2010, 302, 531.
- S. Dibbert, B. Clement, T. Skak-Nielsen, U. Mrowietz, M. Rostami- Yazdi, Arch. Dermatol. Res. 2013, 305, 447.
- D. Werdenberg, R. Joshi, S. Wolffram, H. P. Merkle, P. Langguth, Biopharm. Drug Dispos. 2003, 24, 259.
- N. H. Litjens, J. Burggraaf, E. van Strijen, C. van Gulpen, H. Mattie, R. C. Schoemaker, J. T. van Dissel, H. B. Thio, P. H. Nibbering, Br. J. Clin. Pharmacol. 2004, 58, 429.
- U. Mrowietz, E. Christophers, P. Altmeyer, Br. J. Dermatol. 1999, 141, 424.
- K. Tulpule, R. Dringen, J. Neurochem. 2013, 127, 7.
- M. Rostami-Yazdi, B. Clement, T. J. Schmidt, D. Schinor, U. Mrowietz, J. Invest. Dermatol. 2009, 129, 231.
- N. H. Litjens, E. van Strijen, C. van Gulpen, H. Mattie, J. T. van Dissel, H. B. Thio, P. H. Nibbering, BMC Pharmacol. 2004, 4, 22.
- T. J. Schmidt, M. Ak, U. Mrowietz, Bioorg. Med. Chem. 2007, 15, 333.
- J. D. Peterson, L. A. Herzenberg, K. Vasquez, C. Waltenbaugh, Proc. Natl. Acad. Sci. U. S. A. 1998, 95, 3071.
- M. M. Schmidt, R. Dringen, Neurochem. Int. 2010, 57, 460.
- R. H. Scannevin, S. Chollate, M. Y. Jung, M. Shackett, H. Patel, P. Bista, W. Zeng, S. Ryan, M. Yamamoto, M. Lukashev, K. J. Rhodes, J. Pharmacol. Exp. Ther. 2012, 341, 274.
- F. Kees, Expert Opin. Pharmacother. 2013, 14, 1559.
- U. Mrowietz, P. J. Morrison, I. Suhrkamp, M. Kumanova, B. Clement, Trends Pharmacol. Sci. 2018, 39, 1.
- P. Albrecht, I. Bouchachia, N. Goebels, N. Henke, H. H. Hofstetter, A. Issberner, Z. Kovacs, J. Lewerenz, D. Lisak, P. Maher, A. K. Mausberg, K. Quasthoff, C. Zimmermann, H. P. Hartung, A. Methner, J. Neuroinflammation 2012, 9, 163.
- K. Wallbrecht, N. Drick, A. C. Hund, M. P. Schon, Exp. Dermatol. 2011, 20, 980.
- H. Wilms, J. Sievers, U. Rickert, M. Rostami-Yazdi, U. Mrowietz, R. Lucius, J. Neuroinflammation 2010, 7, 1.
- R. A. Linker, D. H. Lee, S. Ryan, A. M. van Dam, R. Conrad, P. Bista, W. Zeng, X. Hronowsky, A. Buko, S. Chollate, G. Ellrichmann, W. Brück, K. Dawson, S. Goelz, S. Wiese, R. H. Scannevin, M. Lukashev, R. Gold, Brain 2011, 134, 678.
- R. Gold, R. A. Linker, M. Stangel, Clin. Immunol. 2012, 142, 44.
- M. Vandermeeren, S. Janssens, M. Borgers, J. Geysen, Biochem. Biophys. Res. Commun. 1997, 234, 19.
- M. Vandermeeren, S. Janssens, H. Wouters, I. Borghmans, M. Borgers, R. Beyaert, J. Geysen, J. Invest. Dermatol. 2001, 116, 124.
- R. Loewe, M. Pillinger, R. de Martin, U. Mrowietz, M. Gröger, W. Holnthoner, K. Wolff, W. Wiegrebe, D. Jirovsky, P. Petzelbauer, J. Invest. Dermatol. 2001, 117, 1363.
- R. Loewe, W. Holnthoner, M. Groger, M. Pillinger, F. Gruber, D. Mechtcheriakova, E. Hofer, K. Wolff, P. Petzelbauer, J. Immunol. 2002, 168, 4781.
- N. H. Litjens, M. Rademaker, B. Ravensbergen, D. Rea, M. J. van der Plas, B. Thio, A. Walding, J. T. van Dissel, P. H. Nibbering, Eur. J. Immunol. 2004, 34, 565.
- U. Mrowietz, K. Asadullah, Trends Mol. Med. 2005, 11, 43.
- S. Gerdes, K. Shakery, U. Mrowietz, Br. J. Dermatol. 2007, 156, 838.
- D. Moharregh-Khiabani, R. A. Linker, R. Gold, M. Stangel, Curr. Neuropharmacol. 2009, 7, 60.
- H. Peng, M. Guerau-de-Arellano, V. B. Mehta, Y. Yang, D. J. Huss, T. L. Papenfuss, A. E. Lovett-Racke, M. K. Racke, J. Biol. Chem. 2012, 287, 28017.
- H. Moed, T. J. Stoof, D. M. Boorsma, B. M. von Blomberg, S. Gibbs, D. P. Bruynzeel, R. J. Scheper, T. Rustemeyer, Clin. Exp. Allergy 2004, 34, 1868.
- N. H. Litjens, M. Rademaker, B. Ravensbergen, H. B. Thio, J. T. van Dissel, P. H. Nibbering, Br. J. Dermatol. 2006, 154, 211.
- H. Tang, J. Y. Lu, X. Zheng, Y. Yang, J. D. Reagan, Biochem. Biophys. Res. Commun. 2008, 375, 562.
- J. Hanson, A. Gille, S. Zwykiel, M. Lukasova, B. E. Clausen, K. Ahmed, S. Tunaru, A. Wirth, S. Offermanns, J. Clin. Invest. 2010, 120, 2910.
- J. Hanson, A. Gille, S. Offermanns, Pharmacol. Ther. 2012, 136, 1.
- H. Chen, J. C. Assmann, A. Krenz, M. Rahman, M. Grimm, C. M. Karsten, J. Köhl, S. Offermanns, N. Wettschureck, M. Schwaninger, J. Clin. Invest. 2014, 124, 2188.
- G. Zhao, Y. Liu, J. Fang, Y. Chen, H. Li, K. Gao, Biochem. Biophys. Res. Commun. 2014, 448, 303.
- Y. Li, J. Tang, Y. Hu, Biochem. Biophys. Res. Commun. 2014, 454, 257.
- H. J. Kang, H. A. Seo, Y. Go, C. J. Oh, N. H. Jeoung, K. G. Park, I. K. Lee, PLoS ONE 2013, 8, e61411.
- F. Treumer, K. Zhu, R. Glaser, U. Mrowietz, J. Invest. Dermatol. 2003, 121, 1383.
- M. Ghashghaeinia, D. Bobbala, T. Wieder, S. Koka, J. Brück, B. Fehrenbacher, M. Röcken, M. Schaller, F. Lang, K. Ghoreschi, Am. J. Physiol. Cell Physiol. 2010, 299, C791.
- X. Xie, Y. Zhao, C. Y. Ma, X. M. Xu, Y. Q. Zhang, C. G. Wang, J. Jin, X. Shen, J. L. Gao, N. Li, Z. J. Sun, D. L. Dong, Br. J. Pharmacol. 2015, 172, 3929.
- J. P. Nicolay, K. Muller-Decker, A. Schroeder, M. Brechmann, M. Möbs, C. Géraud, C. Assaf, S. Goerdt, P. H. Krammer, K. Gülow, Blood 2016, 128, 805.
- J. Ryu, M. J. Kwon, T. J. Nam, Mar. Drugs. 2015, 13, 4721.
- I. Numata, R. Okuyama, A. Memezawa, Y. Ito, K. Takeda, K. Furuyama, S. Shibahara, S. Aiba, J. Invest. Dermatol. 2009, 129, 2594.
- C. Biswas, N. Shah, M. Muthu, P. La, A. P. Fernando, S. Sengupta, G. Yang, P. A. Dennery, J. Biol. Chem. 2014, 289, 26882.
- U. Schulze-Topphoff, M. Varrin-Doyer, K. Pekarek, R. Scannevin, S. Zamvil, Neurology 2014, 82, S53.
- M. S. Brennan, H. Patel, N. Allaire, A. Thai, P. Cullen, S. Ryan, M. Lukashev, P. Bista, R. Huang, K. J. Rhodes, R. H. Scannevin, Antioxid. Redox Signal. 2016, 24, 1058.
- J. Geisel, J. Brück, I. Glocova, K. Dengler, T. Sinnberg, O. Rothfuss, M. Walter, K. Schulze-Osthoff, M. Röcken, K. Ghoreschi, J. Immunol. 2014, 192, 3530.
- J. Brück, J. Holstein, I. Glocova, U. Seidel, J. Geisel, T. Kanno, J. Kumagai, N. Mato, S. Sudowe, K. Widmaier, T. Sinnberg, A. S. Yazdi, F. C. Eberle, K. Hirahara, T. Nakayama, M. Röcken, K. Ghoreschi, Sci. Rep. 2017, 7, 44482.
- M. K. Kwak, N. Wakabayashi, T. W. Kensler, Mutat. Res. 2004, 555, 133.
- Y. Zhang, G. B. Gordon, Mol. Cancer Ther. 2004, 3, 885.
- Y. Li, J. D. Paonessa, Y. Zhang, PLoS ONE 2012, 7, e35122.
- A. Gegotek, E. Skrzydlewska, Arch. Dermatol. Res. 2015, 307, 385.
- S. Müller, N. Smatlik, M. Burian, K. Ghoreschi, M. Röcken, A. S. Yazdi, J. Dermatol. Sci. 2017, 87, 246.
- A. J. Onderdijk, D. M. Balak, E. M. Baerveldt, E. F. Florencia, M. Kant, J. D. Laman, W. F. van IJcken, E. Racz, D. de Ridder, H. B. Thio, E. P. Prens, Br. J. Dermatol. 2014, 171, 732.
- I. Helwa, V. Choudhary, X. Chen, I. Kaddour-Djebbar, W. B. Bollag, J. Pharmacol. Exp. Ther. 2017, 362, 243.
- H. Ashrafian, G. Czibik, M. Bellahcene, D. Aksentijević, A. C. Smith, S. J. Mitchell, M. S. Dodd, J. Kirwan, J. J. Byrne, C. Ludwig, H. Isackson, A. Yavari, N. B. Støttrup, H. Contractor, T. J. Cahill, N. Sahgal, D. R. Ball, R. I. Birkler, I. Hargreaves, D. A. Tennant, J. Land, C. A. Lygate, M. Johannsen, R. K. Kharbanda, S. Neubauer, C. Redwood, R. de Cabo, I. Ahmet, M. Talan, U. L. Günther, A. J. Robinson, M. R. Viant, P. J. Pollard, D. J. Tyler, H. Watkins, Cell Metab. 2012, 15, 361.
- A. Wierinckx, J. Breve, D. Mercier, M. Schultzberg, B. Drukarch, A. M. Van Dam, J. Neuroimmunol. 2005, 166, 132.
- A. Thiessen, M. M. Schmidt, R. Dringen, Neurosci. Lett. 2010, 475, 56.
- T. J. Stoof, J. Flier, S. Sampat, C. Nieboer, C. P. Tensen, D. M. Boorsma, Br. J. Dermatol. 2001, 144, 1114.
- I. Kastrati, M. I. Siklos, E. L. Calderon-Gierszal, L. El-Shennawy, G. Georgieva, E. N. Thayer, G. R. Thatcher, J. Frasor, J. Biol. Chem. 2016, 291, 3639.
- A. Haarmann, M. Nehen, A. Deiss, M. Buttmann, Int. J. Mol. Sci. 2015, 16, 19086.
- T. A. Libermann, D. Baltimore, Mol. Cell. Biol. 1990, 10, 2327.
- S. Takegawa, Z. Jin, T. Nakayama, T. Oyama, K. Hieshima, D. Nagakubo, A. K. Shirakawa, T. Tsuzuki, S. Nakamura, O. Yoshie, Cancer Sci. 2008, 99, 296.
- M. Hinz, P. Lemke, I. Anagnostopoulos, C. Hacker, D. Krappmann, S. Mathas, B. Dörken, M. Zenke, H. Stein, C. Scheidereit, J. Exp. Med. 2002, 196, 605.
- C. S. Simpson, B. J. Morris, J. Biol. Chem. 2000, 275, 16879.
- J. T. Chai, J. E. Digby, R. P. Choudhury, Curr. Atheroscler. Rep. 2013, 15, 325.
- E. Kolaczkowska, P. Kubes, Nat. Rev. Immunol. 2013, 13, 159.
- R. W. Walters, A. K. Shukla, J. J. Kovacs, J. D. Violin, S. M. DeWire, C. M. Lam, J. R. Chen, M. J. Muehlbauer, E. J. Whalen, R. J. Lefkowitz, J. Clin. Invest. 2009, 119, 1312.
- A. Torales-Cardeña, I. Martínez-Torres, S. Rodríguez-Martínez, F. Gómez-Chávez, J. C. Cancino-Díaz, E. A. Vázquez-Sánchez, M. E. Cancino-Díaz, Mediators Inflamm. 2015, 2015, 607363.
- K. Zhu, U. Mrowietz, J. Invest. Dermatol. 2001, 116, 203.
- S. Eminel, N. Jin, M. Rostami, S. Dibbert, U. Mrowietz, I. Suhrkamp, Exp. Dermatol. 2017, 26, 685.
- V. A. McGuire, T. Ruiz-Zorrilla Diez, C. H. Emmerich, S. Strickson, M. S. Ritorto, R. V. Sutavani, A. Weib, K. F. Houslay, A. Knebel, P. J. Meakin, I. R. Phair, M. L. Ashford, M. Trost, J. S. Arthur, Sci. Rep. 2016, 6, 31159.
- S. E. Fiedler, A. R. Kerns, C. Tsang, V. Tsang, D. Bourdette, S. Salinthone, Biochem. Biophys. Res. Commun. 2016, 475, 19.
- J. Zhu, H. Yamane, W. E. Paul, Annu. Rev. Immunol. 2010, 28, 445.
- J. Pène, S. Chevalier, L. Preisser, E. Vénéreau, M. H. Guilleux, S. Ghannam, J. P. Molès, Y. Danger, E. Ravon, S. Lesaux, H. Yssel, H. Gascan, J. Immunol. 2008, 180, 7423.
- K. Ghoreschi, P. Thomas, S. Breit, M. Dugas, R. Mailhammer, W. van Eden, R. van der Zee, T. Biedermann, J. Prinz, M. Mack, U. Mrowietz, E. Christophers, D. Schlöndorff, G. Plewig, C. A. Sander, M. Röcken, Nat. Med. 2003, 9, 40.
- M. K. Racke, A. Bonomo, D. E. Scott, B. Cannella, A. Levine, C. S. Raine, E. M. Shevach, M. Röcken, J. Exp. Med. 1994, 180, 1961.
- P. H. Hart, R. L. Cooper, J. J. Finlay-Jones, Immunology 1991, 72, 344.
- H. L. Wong, G. L. Costa, M. T. Lotze, S. M. Wahl, J. Exp. Med. 1993, 177, 775.
- E. Guenova, T. Volz, K. Sauer, S. Kaesler, M. R. Müller, F. Wölbing, K. Chen, C. Schwärzler, P. Brossart, M. Röcken, T. Biedermann, Eur. J. Immunol. 2008, 38, 3138.
- R. Debets, J. P. Hegmans, P. Croughs, R. J. Troost, J. B. Prins, R. Benner, E. P. Prens, J. Immunol. 1997, 158, 2955.
- W. A. Goodman, A. D. Levine, J. V. Massari, H. Sugiyama, T. S. McCormick, K. D. Cooper, J. Immunol. 2009, 183, 3170.
- E. Rácz, D. Kurek, M. Kant, E. M. Baerveldt, E. Florencia, S. Mourits, D. de Ridder, J. D. Laman, L. van der Fits, E. P. Prens, PLoS ONE 2011, 6, e19806.
- A. J. Onderdijk, E. M. Baerveldt, D. Kurek, M. Kant, E. F. Florencia, R. Debets, E. P. Prens, J. Immunol. 2015, 195, 1744.
- M. Hahn, K. Ghoreschi, Expert Rev. Clin. Immunol. 2017, 13, 171.
- E. Guenova, Y. Skabytska, W. Hoetzenecker, G. Weindl, K. Sauer, M. Tham, K. W. Kim, J. H. Park, J. H. Seo, D. Ignatova, A. Cozzio, M. P. Levesque, T. Volz, M. Köberle, S. Kaesler, P. Thomas, R. Mailhammer, K. Ghoreschi, K. Schäkel, B. Amarov, M. Eichner, M. Schaller, R. A. Clark, M. Röcken, T. Biedermann, Proc. Natl. Acad. Sci. U. S. A. 2015, 112, 2163.
- M. L. Roberti, L. Ricottini, A. Capponi, E. Sclauzero, P. Vicenti, E. Fiorentini, C. Savoia, G. Scornavacca, D. Brazioli, L. Gaio, R. Giannetti, C. Ignazzi, G. Meloni, L. M. Chinni, J. Biol. Regul. Homeost. Agents 2014, 28, 133.
- M. Friedrich, W. D. Döcke, A. Klein, S. Philipp, H. D. Volk, W. Sterry, K. Asadullah, J. Invest. Dermatol. 2002, 118, 672.
- K. Asadullah, W. D. Döcke, M. Ebeling, M. Friedrich, G. Belbe, H. Audring, H. D. Volk, W. Sterry, Arch. Dermatol. 1999, 135, 187.
- A. B. Kimball, T. Kawamura, K. Tejura, C. Boss, A. R. Hancox, J. C. Vogel, S. M. Steinberg, M. L. Turner, A. Blauvelt, Arch. Dermatol. 2002, 138, 1341.
- K. Reich, C. Garbe, V. Blaschke, C. Maurer, P. Middel, G. Westphal, U. Lippert, C. Neumann, J. Invest. Dermatol. 2001, 116, 319.
- I. B. McInnes, G. G. Illei, C. L. Danning, C. H. Yarboro, M. Crane, T. Kuroiwa, R. Schlimgen, E. Lee, B. Foster, D. Flemming, C. Prussin, T. A. Fleisher, D. T. Boumpas, J. Immunol. 2001, 167, 4075.
- W. L. Trepicchio, M. Ozawa, I. B. Walters, T. Kikuchi, P. Gilleaudeau, J. L. Bliss, U. Schwertschlag, A. J. Dorner, J. G. Krueger, J. Clin. Invest. 1999, 104, 1527.
- S. Müller, M. Behnen, K. Bieber, S. Möller, L. Hellberg, M. Witte, M. Hänsel, D. Zillikens, W. Solbach, T. Laskay, R. J. Ludwig, J. Invest. Dermatol. 2016, 136, 117.
- E. E. Longbrake, M. J. Ramsbottom, C. Cantoni, L. Ghezzi, A. H. Cross, L. Piccio, Mult. Scler. 2016, 22, 1061.
- J. R. Bjerke, H. K. Krogh, R. Matre, J. Invest. Dermatol. 1978, 71, 340.
- E. Christophers, G. Metzler, M. Röcken, Br. J. Dermatol. 2014, 170, 59.
- H. M. Ockenfels, T. Schultewolter, G. Ockenfels, R. Funk, M. Goos, Br. J. Dermatol. 1998, 139, 390.
- B. Gesser, M. K. Rasmussen, L. Raaby, C. Rosada, C. Johansen, R. B. Kjellerup, K. Kragballe, L. Iversen, Inflamm. Res. 2011, 60, 643.
- B. Gesser, C. Johansen, M. K. Rasmussen, A. T. Funding, K. Otkjaer, R. B. Kjellerup, K. Kragballe, L. Iversen, J. Invest. Dermatol. 2007, 127, 2129.
- S. Höxtermann, C. Nuchel, P. Altmeyer, Dermatology 1998, 196, 223.
- W. Sondermann, N. Rompoti, L. Leister, L. Huptas, J. Klode, J. Dissemond, A. Körber, Dermatology 2017, 233, 295.
- Q. Wu, Q. Wang, G. Mao, C. A. Dowling, S. K. Lundy, Y. Mao- Draayer, J. Immunol. 2017, 198, 3069.
- S. A. Rubant, R. J. Ludwig, S. Diehl, K. Hardt, R. Kaufmann, J. M. Pfeilschifter, W. H. Boehncke, J. Invest. Dermatol. 2008, 128, 326.
- Y. Kihara, A. Groves, R. R. Rivera, J. Chun, Ann. Clin. Transl. Neurol. 2015, 2, 978.
- S. Zoghi, Z. Amirghofran, A. Nikseresht, N. Ashjazadeh, E. Kamali- Sarvestani, N. Rezaei, Immunol. Invest. 2011, 40, 581.
- S. Tahvili, B. Zandieh, Z. Amirghofran, Int. J. Dermatol. 2015, 54, e254.
- C. C. Gross, A. Schulte-Mecklenbeck, S. Klinsing, A. Posevitz- Fejfár, H. Wiendl, L. Klotz, Neurol. Neuroimmunol. Neuroinflamm. 2016, 3, e183.
- H. J. Bovenschen, A. M. Langewouters, P. C. van de Kerkhof, Am. J. Clin. Dermatol. 2010, 11, 343.
- R. Gold, L. Kappos, D. L. Arnold, A. Bar-Or, G. Giovannoni, K. Selmaj, C. Tornatore, M. T. Sweetser, M. Yang, S. I. Sheikh, K. T. Dawson; DEFINE Study Investigators, N. Engl. J. Med. 2012, 367, 1098.
- R. J. Fox, D. H. Miller, J. T. Phillips, M. Hutchinson, E. Havrdova, M. Kita, M. Yang, K. Raghupathi, M. Novas, M. T. Sweetser, V. Viglietta, K. T. Dawson, CONFIRM Study Investigators, N. Engl. J. Med. 2012, 367, 1087.
- C. M. Spencer, E. C. Crabtree-Hartman, K. Lehmann-Horn, B. A. Cree, S. S. Zamvil, Neurol. Neuroimmunol. Neuroinflamm. 2015, 2, e76.
- M. Ghadiri, A. Rezk, R. Li, A. Evans, F. Luessi, F. Zipp, P. S. Giacomini, J. Antel, A. Bar-Or, Neurol. Neuroimmunol. Neuroinflamm. 2017, 4, e340.
- D. M. W. Balak, E. Hajdarbegovic, W. M. Bramer, H. A. M. Neumann, H. B. Thio, J. Eur. Acad. Dermatol. Venereol. 2017, 31, 1475.
- J. H. O. Hoffmann, K. Schaekel, D. Hartl, A. H. Enk, E. N. Hadaschik, Br. J. Dermatol.. 2018, 178, 207
- P. H. Nibbering, B. Thio, T. P. Zomerdijk, A. C. Bezemer, R. L. Beijersbergen, R. van Furth, J. Invest. Dermatol. 1993, 101, 37.
- I. Helwa, R. Patel, P. Karempelis, I. Kaddour-Djebbar, V. Choudhary, W. B. Bollag, J. Pharmacol. Exp. Ther. 2015, 352, 90.
- B. Sebök, B. Bonnekoh, R. Vetter, I. Schneider, H. Gollnick, G. Mahrle, Eur. J. Dermatol. 1998, 8, 29.
- B. Bonnekoh, R. Bockelmann, A. Ambach, H. Gollnick, Skin Pharmacol. Appl. Skin Physiol. 2001, 14, 217.
- R. Heidenreich, M. Röcken, K. Ghoreschi, Drug News. Perspect. 2008, 21, 97.
- M. Meissner, M. Doll, I. Hrgovic, G. Reichenbach, V. König, T. Hailemariam-Jahn, J. Gille, R. Kaufmann, J. Invest. Dermatol. 2011, 131, 1356.
- M. Garcia-Caballero, M. Mari-Beffa, M. A. Medina, A. R. Quesada, J. Invest. Dermatol. 2011, 131, 1347.
- J. L. Arbiser, J. Invest. Dermatol. 2011, 131, 1189.
- C. Nieboer, D. de Hoop, P. N. Langendijk, A. C. van Loenen, J. Gubbels, Dermatologica 1990, 181, 33.
- M. Wakkee, H. B. Thio, Curr. Opin. Investig. Drugs 2007, 8, 955.
- M. Meissner, E. M. Valesky, S. Kippenberger, R. Kaufmann, J. Dtsch. Dermatol. Ges. 2012, 10, 793.
Cited by
Sorted by citations
Coupling Krebs cycle metabolites to signalling in immunity and cancer
Ryan, D. G., Murphy, M. P., Frezza, C., Prag, H. A., Chouchani, E. T., O’Neill, L. A., & Mills, E. L. (2018) · Nature Metabolism · doi:10.1038/s42255-018-0014-7 · Cited by 398 · see citing works
Thirty years of NRF2: advances and therapeutic challenges.
Zhang, D. D. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01145-0 · Cited by 282 · see citing works
Dimethyl fumarate: targeting glycolysis to treat MS
Angiari, S., & O’Neill, L. A. (2018) · Cell Research · doi:10.1038/s41422-018-0045-3 · Cited by 27 · see citing works
- Authors
- Brück, J., Dringen, R., Amasuno, A., Pau‐Charles, I., & Ghoreschi, K.
- Affiliations
- University of Tübingen (DE)
- University of Bremen (DE)
- Almirall (Spain) (ES)
- Corresponding author
- Ghoreschi, Kamran
- Venue
- Experimental Dermatology
- Publisher
- Wiley
- Published
- 2018-04-25
- Volume
- 27
- Issue
- 6
- Pages
- 611-624
- ISSN
- 0906-6705 (ISSN-L)
- 1600-0625
- OpenAlex
- W2795256497
- Cited by
- 128
- References
- 172
- Citations by year
- 2026: 12 · 2025: 18 · 2024: 7 · 2023: 13 · 2022: 20 · 2021: 25 · 2020: 21 · 2019: 9 · 2018: 3
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Experimental Dermatology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft (Sonderforschungsbereich (SFB) TR‐156, TP A06)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
- Health Sciences › Medicine › Rheumatology › Spondyloarthritis Studies and Treatments
- Keywords
- dimethyl fumarate, fumaric acid esters, psoriasis, glutathione, Nrf2, NF-κB, HIF-1α, Th2 immune response, inflammatory cytokines, granulocytes, keratinocytes, endothelial cells, anti-inflammatory mechanism, immunomodulation
- MeSH terms
- Dimethyl Fumarate, Animals, Dermatologic Agents, Glutathione, Humans, Lymphocytes, Neutrophils, Psoriasis, Signal Transduction, Down-Regulation, Keratinocytes, Cytokines, NF-kappa B, Endothelial Cells, Receptors, G-Protein-Coupled, NF-E2-Related Factor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review